<?xml version="1.0" encoding="UTF-8" standalone="yes"?>
<MSIGDB NAME="search results" VERSION="V5.1" BUILD_DATE="Jan 9, 2016">
    <GENESET SUB_CATEGORY_CODE="CP:BIOCARTA" ORGANISM="Homo sapiens" CATEGORY_CODE="C2" STANDARD_NAME="BIOCARTA_CHREBP2_PATHWAY" SYSTEMATIC_NAME="M1940" HISTORICAL_NAMES="" PMID="" VALIDATION_DATASETS="" REFINEMENT_DATASETS="" GEOID="" EXACT_SOURCE="" CHIP="EntrezGeneIds" AUTHORS="" CONTRIBUTOR="BioCarta" CONTRIBUTOR_ORG="BioCarta" EXTERNAL_DETAILS_URL="http://cgap.nci.nih.gov/Pathways/BioCarta/h_Chrebp.2Pathway" GENESET_LISTING_URL="http://cgap.nci.nih.gov/Genes/PathGeneQuery?PAGE=1&amp;ORG=Hs&amp;PATH=h_Chrebp.2Pathway" DESCRIPTION_BRIEF="Regulation And Function Of ChREBP in Liver" DESCRIPTION_FULL="Liver is the major site for carbohydrate metabolism (glycolysis and glycogen synthesis) and triglyceride synthesis (lipogenesis). While insulin was long thought to be the major regulator of hepatic gene expression, emerging evidence show that nutrients, in particular, glucose and fatty acids, are also able to regulate hepatic genes. This diagram illustrates how glucose metabolite, rather than glucose itself, contributes to the coordinated regulation of carbohydrate and lipid homeostasis in liver through phosphorylation-dependent regulation of ChREBP (carbohydrate responsive element binding protein). ChREBP is a basic helix-loop helix/leucine zipper (bHLH/LZ) transcription factor, shuttling between the cytoplasm and nucleus in a glucose-responsive manner in hepatocytes. When serum glucose is elevated, glucose transporter (GLUT2) and glucokinase (GCK) allow for rapid uptake and equilibration of intracellular glucose levels. This flux of glucose promotes, via the hexose monophosphate shunt pathway (HMP Shunt), the formation of xylulose-5-phosphate (Xu-5-P), which activates protein phosphatase 2A (PP2A) to dephosphorylate ChREBP (Ser196) and promote its nuclear localization. PP2A further dephosphorylates ChREBP in the nucleus, allowing it to dimerize with the bHLH/LZ transcription factor Max-like protein X (MLX) and activate transcription of a number of glycolytic and lipogenic genes containing a ChoRE, such as liver-type pyruvate kinase (L-PK), acetyl-CoA carboxylase 1 (ACACA), and fatty acid synthase (FASN). Upon starvation or high-fat feeding, intrahepatic levels of cAMP and AMP are elevated to activate protein kinase A (PKA) and AMP-dependent protein kinase (AMPK), respectively. PKA-mediated phosphorylation of Thr666 and Ser626 inhibits the DNA binding capacity of ChREBP; so does AMPK-mediated modification of Ser568. PKA-dependent phosphorylation of Ser196 promotes interaction with 14-3-3 and thus sequesters ChREBP in the cytosol. In summary, the phosphorylated form of ChREBP is rendered inactive due to its diminished DNA binding capacity and subcellular compartmentalization. Glucose metabolism triggers dephosphorylation of ChREBP, allowing it to enter the nucleus and activate the transcription of both glycolytic and lipogenic gene expression in liver. The fact that ChREBP/ mice are intolerant to glucose and insulin resistant suggests that ChREBP may also play a role in the pathogenesis of type 2 diabetes." TAGS="" MEMBERS="10971,2194,2645,28227,31,51085,51422,5313,53632,5515,5516,5518,5519,5520,5521,5522,5523,5524,5525,5526,5527,5528,5529,5562,5563,5564,5565,5566,5567,5568,5571,5573,5575,5576,5577,55844,6945,7527,7529,7530,7531,7532,7533,7534" MEMBERS_MAPPING="10971,YWHAQ,10971|2194,FASN,2194|2645,GCK,2645|28227,PPP2R3B,28227|31,ACACA,31|51085,MLXIPL,51085|51422,PRKAG2,51422|5313,PKLR,5313|53632,PRKAG3,53632|5515,PPP2CA,5515|5516,PPP2CB,5516|5518,PPP2R1A,5518|5519,PPP2R1B,5519|5520,PPP2R2A,5520|5521,PPP2R2B,5521|5522,PPP2R2C,5522|5523,PPP2R3A,5523|5524,PPP2R4,5524|5525,PPP2R5A,5525|5526,PPP2R5B,5526|5527,PPP2R5C,5527|5528,PPP2R5D,5528|5529,PPP2R5E,5529|5562,PRKAA1,5562|5563,PRKAA2,5563|5564,PRKAB1,5564|5565,PRKAB2,5565|5566,PRKACA,5566|5567,PRKACB,5567|5568,PRKACG,5568|5571,PRKAG1,5571|5573,PRKAR1A,5573|5575,PRKAR1B,5575|5576,PRKAR2A,5576|5577,PRKAR2B,5577|55844,PPP2R2D,55844|6945,MLX,6945|7527,YWHAB,7529|7529,YWHAB,7529|7530,YWHAZ,7534|7531,YWHAE,7531|7532,YWHAG,7532|7533,YWHAH,7533|7534,YWHAZ,7534" MEMBERS_SYMBOLIZED="ACACA,FASN,GCK,MLX,MLXIPL,PKLR,PPP2CA,PPP2CB,PPP2R1A,PPP2R1B,PPP2R2A,PPP2R2B,PPP2R2C,PPP2R2D,PPP2R3A,PPP2R3B,PPP2R4,PPP2R5A,PPP2R5B,PPP2R5C,PPP2R5D,PPP2R5E,PRKAA1,PRKAA2,PRKAB1,PRKAB2,PRKACA,PRKACB,PRKACG,PRKAG1,PRKAG2,PRKAG3,PRKAR1A,PRKAR1B,PRKAR2A,PRKAR2B,YWHAB,YWHAE,YWHAG,YWHAH,YWHAQ,YWHAZ" MEMBERS_EZID="10971,2194,2645,28227,31,51085,51422,5313,53632,5515,5516,5518,5519,5520,5521,5522,5523,5524,5525,5526,5527,5528,5529,5562,5563,5564,5565,5566,5567,5568,5571,5573,5575,5576,5577,55844,6945,7529,7531,7532,7533,7534" FOUNDER_NAMES=""/>
    <GENESET SUB_CATEGORY_CODE="CP:BIOCARTA" ORGANISM="Homo sapiens" CATEGORY_CODE="C2" STANDARD_NAME="BIOCARTA_NUCLEARRS_PATHWAY" SYSTEMATIC_NAME="M16393" HISTORICAL_NAMES="" PMID="" VALIDATION_DATASETS="" REFINEMENT_DATASETS="" GEOID="" EXACT_SOURCE="" CHIP="EntrezGeneIds" AUTHORS="" CONTRIBUTOR="BioCarta" CONTRIBUTOR_ORG="BioCarta" EXTERNAL_DETAILS_URL="http://cgap.nci.nih.gov/Pathways/BioCarta/h_nuclearRsPathway" GENESET_LISTING_URL="http://cgap.nci.nih.gov/Genes/PathGeneQuery?PAGE=1&amp;ORG=Hs&amp;PATH=h_nuclearRsPathway" DESCRIPTION_BRIEF="Nuclear Receptors in Lipid Metabolism and Toxicity" DESCRIPTION_FULL="Nuclear receptors are transcription factors that are activated upon binding to its ligands. Initially, they had been classified as classic endocrine nuclear hormone receptors and orphan receptors. However, further studies have led to the identification of lipid ligands for some of these adopted orphan receptors, which are responsible for lipid metabolism, storage or elimination. One of the characteristics of these receptors is that they act by forming heterodimers with retinoid X receptor (RXR). The receptors include peroxisome proliferators-Activated receptors (PPARs) for fatty acids, liver X receptor (LCR) for oxysterols, Farnesoid X receptors (FXR) for bile acids and steroid xenobiotic receptor/X receptor (SXR/PXR or Nsil2) for xenobiotics. Other orphan receptors also require RXR for its functions are vitamin D receptor (VDR) for vitamin D and retinoic acid receptor (RAR) for retinoid acids, although these receptors are not involved in lipid metabolism. Upon binding to various ligands, three classes of proteins are synthesized including lipid binding proteins, the ATP-binding cassette (ABC) transporters and cytochrome P450 member proteins which catalyzes lipid anabolism, metabolism and elimination. In addition to lipid metabolism, some members of the cytochrome P450 family genes are responsible for activation of procarcinogens, detoxification of environmental toxins and metabolism of drugs and xenobiotics. In particular, CAR, Nsil2 and recently identified VDR are important in up-regulation of these cytochromes. Of all the human cytochrome P450 genes, only a few CYP1A2, CYP2C9, CYP2C19, CYP2D6, CYP2E1 and CYP3A4 account for most toxicity effects, specifically CYP3A is responsible for clearing approximately half of the clinically prescribed drugs. For instance, acetaminophen, one of the most commonly used drug, is toxic in high doses due to the activation of CAR and the drugs subsequentconversion to acetyl-p-benzoquinone imine (NAPQI) by CYP1A2, CYP2E1 and CYP3A." TAGS="" MEMBERS="10062,1544,1571,3410,5243,5244,5465,5467,5468,5914,8431,8647,8714,9970,9971" MEMBERS_MAPPING="10062,NR1H3,10062|1544,CYP1A2,1544|1571,CYP2E1,1571|3410,IDDM11,3410|5243,ABCB1,5243|5244,ABCB4,5244|5465,PPARA,5465|5467,PPARD,5467|5468,PPARG,5468|5914,RARA,5914|8431,NR0B2,8431|8647,ABCB11,8647|8714,ABCC3,8714|9970,NR1I3,9970|9971,NR1H4,9971" MEMBERS_SYMBOLIZED="ABCB1,ABCB11,ABCB4,ABCC3,CYP1A2,CYP2E1,IDDM11,NR0B2,NR1H3,NR1H4,NR1I3,PPARA,PPARD,PPARG,RARA" MEMBERS_EZID="10062,1544,1571,3410,5243,5244,5465,5467,5468,5914,8431,8647,8714,9970,9971" FOUNDER_NAMES=""/>
    <GENESET SUB_CATEGORY_CODE="CP:KEGG" ORGANISM="Homo sapiens" CATEGORY_CODE="C2" STANDARD_NAME="KEGG_ETHER_LIPID_METABOLISM" SYSTEMATIC_NAME="M2130" HISTORICAL_NAMES="" PMID="" VALIDATION_DATASETS="" REFINEMENT_DATASETS="" GEOID="" EXACT_SOURCE="" CHIP="EntrezGeneIds" AUTHORS="" CONTRIBUTOR="KEGG" CONTRIBUTOR_ORG="KEGG" EXTERNAL_DETAILS_URL="http://www.genome.jp/kegg/pathway/hsa/hsa00565.html" GENESET_LISTING_URL="" DESCRIPTION_BRIEF="Ether lipid metabolism" DESCRIPTION_FULL="" TAGS="" MEMBERS="100137049,123745,133121,254531,26279,30814,391013,5048,50487,5049,5050,5051,5168,5319,5320,5321,5322,5337,5338,54947,56994,64600,7941,79888,81579,8398,8399,84647,8540,8611,8612,8613,8681" MEMBERS_MAPPING="100137049,PLA2G4B,100137049|123745,PLA2G4E,123745|133121,ENPP6,133121|254531,LPCAT4,254531|26279,PLA2G2D,26279|30814,PLA2G2E,30814|391013,PLA2G2C,391013|5048,PAFAH1B1,5048|50487,PLA2G3,50487|5049,PAFAH1B2,5049|5050,PAFAH1B3,5050|5051,PAFAH2,5051|5168,ENPP2,5168|5319,PLA2G1B,5319|5320,PLA2G2A,5320|5321,PLA2G4A,5321|5322,PLA2G5,5322|5337,PLD1,5337|5338,PLD2,5338|54947,LPCAT2,54947|56994,CHPT1,56994|64600,PLA2G2F,64600|7941,PLA2G7,7941|79888,LPCAT1,79888|81579,PLA2G12A,81579|8398,PLA2G6,8398|8399,PLA2G10,8399|84647,PLA2G12B,84647|8540,AGPS,8540|8611,PPAP2A,8611|8612,PPAP2C,8612|8613,PPAP2B,8613|8681,JMJD7-PLA2G4B,8681" MEMBERS_SYMBOLIZED="AGPS,CHPT1,ENPP2,ENPP6,JMJD7-PLA2G4B,LPCAT1,LPCAT2,LPCAT4,PAFAH1B1,PAFAH1B2,PAFAH1B3,PAFAH2,PLA2G10,PLA2G12A,PLA2G12B,PLA2G1B,PLA2G2A,PLA2G2C,PLA2G2D,PLA2G2E,PLA2G2F,PLA2G3,PLA2G4A,PLA2G4B,PLA2G4E,PLA2G5,PLA2G6,PLA2G7,PLD1,PLD2,PPAP2A,PPAP2B,PPAP2C" MEMBERS_EZID="100137049,123745,133121,254531,26279,30814,391013,5048,50487,5049,5050,5051,5168,5319,5320,5321,5322,5337,5338,54947,56994,64600,7941,79888,81579,8398,8399,84647,8540,8611,8612,8613,8681" FOUNDER_NAMES=""/>
    <GENESET SUB_CATEGORY_CODE="CP:KEGG" ORGANISM="Homo sapiens" CATEGORY_CODE="C2" STANDARD_NAME="KEGG_PPAR_SIGNALING_PATHWAY" SYSTEMATIC_NAME="M13088" HISTORICAL_NAMES="" PMID="" VALIDATION_DATASETS="" REFINEMENT_DATASETS="" GEOID="" EXACT_SOURCE="" CHIP="EntrezGeneIds" AUTHORS="" CONTRIBUTOR="KEGG" CONTRIBUTOR_ORG="KEGG" EXTERNAL_DETAILS_URL="http://www.genome.jp/kegg/pathway/hsa/hsa03320.html" GENESET_LISTING_URL="" DESCRIPTION_BRIEF="PPAR signaling pathway" DESCRIPTION_FULL="Peroxisome proliferator-activated receptors (PPARs) are nuclear hormone receptors that are activated by fatty acids and their derivatives. PPAR has three subtypes (PPARalpha, beta/delta, and gamma) showing different expression patterns in vertebrates. Each of them is encoded in a separate gene and binds fatty acids and eicosanoids. PPARalpha plays a role in the clearance of circulating or cellular lipids via the regulation of gene expression involved in lipid metabolism in liver and skeletal muscle. PPARbeta/delta is involved in lipid oxidation and cell proliferation. PPARgamma promotes adipocyte differentiation to enhance blood glucose uptake." TAGS="" MEMBERS="10062,10580,10998,10999,11001,116519,126129,1374,1375,1376,1579,1581,1582,1593,1622,1962,2167,2168,2169,2170,2171,2172,2173,2180,2181,2182,23305,2710,2712,284541,28965,30,3158,33,335,336,34,345,3611,364,376497,4023,4199,4312,4973,51,5105,5106,51129,5170,51703,5346,5360,5465,5467,5468,6256,6257,6258,6319,6342,7316,7350,79966,8309,8310,9370,9415,948" MEMBERS_MAPPING="10062,NR1H3,10062|10580,SORBS1,10580|10998,SLC27A5,10998|10999,SLC27A4,10999|11001,SLC27A2,11001|116519,APOA5,116519|126129,CPT1C,126129|1374,CPT1A,1374|1375,CPT1B,1375|1376,CPT2,1376|1579,CYP4A11,1579|1581,CYP7A1,1581|1582,CYP8B1,1582|1593,CYP27A1,1593|1622,DBI,1622|1962,EHHADH,1962|2167,FABP4,2167|2168,FABP1,2168|2169,FABP2,2169|2170,FABP3,2170|2171,FABP5,2171|2172,FABP6,2172|2173,FABP7,2173|2180,ACSL1,2180|2181,ACSL3,2181|2182,ACSL4,2182|23305,ACSL6,23305|2710,GK,2710|2712,GK2,2712|284541,CYP4A22,284541|28965,SLC27A6,28965|30,ACAA1,30|3158,HMGCS2,3158|33,ACADL,33|335,APOA1,335|336,APOA2,336|34,ACADM,34|345,APOC3,345|3611,ILK,3611|364,AQP7,364|376497,SLC27A1,376497|4023,LPL,4023|4199,ME1,4199|4312,MMP1,4312|4973,OLR1,4973|51,ACOX1,51|5105,PCK1,5105|5106,PCK2,5106|51129,ANGPTL4,51129|5170,PDPK1,5170|51703,ACSL5,51703|5346,PLIN1,5346|5360,PLTP,5360|5465,PPARA,5465|5467,PPARD,5467|5468,PPARG,5468|6256,RXRA,6256|6257,RXRB,6257|6258,RXRG,6258|6319,SCD,6319|6342,SCP2,6342|7316,UBC,7316|7350,UCP1,7350|79966,SCD5,79966|8309,ACOX2,8309|8310,ACOX3,8310|9370,ADIPOQ,9370|9415,FADS2,9415|948,CD36,948" MEMBERS_SYMBOLIZED="ACAA1,ACADL,ACADM,ACOX1,ACOX2,ACOX3,ACSL1,ACSL3,ACSL4,ACSL5,ACSL6,ADIPOQ,ANGPTL4,APOA1,APOA2,APOA5,APOC3,AQP7,CD36,CPT1A,CPT1B,CPT1C,CPT2,CYP27A1,CYP4A11,CYP4A22,CYP7A1,CYP8B1,DBI,EHHADH,FABP1,FABP2,FABP3,FABP4,FABP5,FABP6,FABP7,FADS2,GK,GK2,HMGCS2,ILK,LPL,ME1,MMP1,NR1H3,OLR1,PCK1,PCK2,PDPK1,PLIN1,PLTP,PPARA,PPARD,PPARG,RXRA,RXRB,RXRG,SCD,SCD5,SCP2,SLC27A1,SLC27A2,SLC27A4,SLC27A5,SLC27A6,SORBS1,UBC,UCP1" MEMBERS_EZID="10062,10580,10998,10999,11001,116519,126129,1374,1375,1376,1579,1581,1582,1593,1622,1962,2167,2168,2169,2170,2171,2172,2173,2180,2181,2182,23305,2710,2712,284541,28965,30,3158,33,335,336,34,345,3611,364,376497,4023,4199,4312,4973,51,5105,5106,51129,5170,51703,5346,5360,5465,5467,5468,6256,6257,6258,6319,6342,7316,7350,79966,8309,8310,9370,9415,948" FOUNDER_NAMES=""/>
    <GENESET SUB_CATEGORY_CODE="CP:REACTOME" ORGANISM="Homo sapiens" CATEGORY_CODE="C2" STANDARD_NAME="REACTOME_PEROXISOMAL_LIPID_METABOLISM" SYSTEMATIC_NAME="M2286" HISTORICAL_NAMES="" PMID="" VALIDATION_DATASETS="" REFINEMENT_DATASETS="" GEOID="" EXACT_SOURCE="" CHIP="EntrezGeneIds" AUTHORS="" CONTRIBUTOR="Reactome" CONTRIBUTOR_ORG="Reactome" EXTERNAL_DETAILS_URL="http://www.reactome.org/cgi-bin/eventbrowser_st_id?ST_ID=REACT_16957" GENESET_LISTING_URL="" DESCRIPTION_BRIEF="Genes involved in Peroxisomal lipid metabolism" DESCRIPTION_FULL="" TAGS="" MEMBERS="10005,10478,11001,1384,215,23600,26061,30,3295,3417,51,5264,54677,55711,6342,642762,8309,8310,84188,8443,8540" MEMBERS_MAPPING="10005,ACOT8,10005|10478,SLC25A17,10478|11001,SLC27A2,11001|1384,CRAT,1384|215,ABCD1,215|23600,AMACR,23600|26061,HACL1,26061|30,ACAA1,30|3295,HSD17B4,3295|3417,IDH1,3417|51,ACOX1,51|5264,PHYH,5264|54677,CROT,54677|55711,FAR2,55711|6342,SCP2,6342|642762,ABCD1P5,642762|8309,ACOX2,8309|8310,ACOX3,8310|84188,FAR1,84188|8443,GNPAT,8443|8540,AGPS,8540" MEMBERS_SYMBOLIZED="ABCD1,ABCD1P5,ACAA1,ACOT8,ACOX1,ACOX2,ACOX3,AGPS,AMACR,CRAT,CROT,FAR1,FAR2,GNPAT,HACL1,HSD17B4,IDH1,PHYH,SCP2,SLC25A17,SLC27A2" MEMBERS_EZID="10005,10478,11001,1384,215,23600,26061,30,3295,3417,51,5264,54677,55711,6342,642762,8309,8310,84188,8443,8540" FOUNDER_NAMES=""/>
</MSIGDB>
